Aurobindo Pharma Revenue
Pharmaceutical Manufacturing • 
Serilingampalli, Telangana, India • 10000+ Employees
Aurobindo Pharma revenue & valuation
| Annual revenue | $3,480,500,000 |
| Revenue per employee | $238,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $11,137,300,000 |
| Total funding | No funding |
Key Contacts at Aurobindo Pharma
Sanjay Chaturvedi
Chief Executive Officer
Satakarni Makkapati B.Engg
Member Board Of Directors
Umesh K
Associate President - Global Access & Licensing Ii President Director, Pt Aurogen Pharma Indonesia
Jonathan Farrugia
Managing Director Aurobindo Malta And European Quality Director Aurobindo Europe
Massimo Micheli
Managing Director
Rajeev Kumar
General Director Mexico
P Sarath Chandra Reddy
Director
Wout Wielaard
Managing Director Pharmacin Bv
Dave Palew
Director Supply Chain
Neelam Kumari
General Director Internacional Business
Company overview
| Headquarters | Galaxy, Floors: 22-24, Plot No.1, Survey No.83/1, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District,, Hyderabad, Telangana 500032, IN |
| Phone number | +914066725000 |
| Website | |
| NAICS | 3254 |
| SIC | 283 |
| Keywords | API, R&D, Formulation, Oncology, Specialty, Enzymes, Biologics, Generics, Injectables, Vaccine |
| Founded | 1986 |
| Employees | 10000+ |
| Socials |
Aurobindo Pharma Email Formats
Aurobindo Pharma uses 5 email formats. The most common is {first name}.{last name} (e.g., john.doe@aurobindo.com), used 34.2% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@aurobindo.com | 34.2% |
{first initial}.{last name} | j.doe@aurobindo.com | 30.7% |
{first name}{last name} | johndoe@aurobindousa.com | 20.1% |
{first initial}{last name} | jdoe@aurobindousa.com | 4.3% |
{first initial}{second initial}.{last name} | jo.doe@aurobindo.com | 1.7% |
About Aurobindo Pharma
Aurobindo Pharma Limited (NSE: AUROPHARMA, BSE: 524804, Reuters: ARBN.NS, Bloomberg: ARBP IN) is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and markets a wide range of generic pharmaceuticals, branded specialty drugs, and active pharmaceutical ingredients (APIs) across more than 150 countries. It is ranked among the top 10 generic companies in eight European nations and holds the distinction of being the largest generic pharmaceutical company in the United States. With over 30 state-of-the-art manufacturing and packaging facilities approved by leading global regulatory authorities including USFDA, UK MHRA, EDQM, Japan PMDA, WHO, Health Canada, South Africa MCC, and Brazil ANVISA, Aurobindo Pharma ensures the highest standards of quality. Its robust portfolio spans eight major therapeutic areas: Central Nervous System (CNS), Antiretroviral (ARV), Cardiovascular (CVS), Antibiotics, Gastroenterology, Anti-diabetics, Oncology, and Dermatology, supported by a strong R&D infrastructure that drives innovation, affordability, and accessibility.
Employees by Management Level
Total employees: 10000+
Seniority
Employees
Employees by Department
Aurobindo Pharma has 4,185 employees across 19 departments.
Departments
Number of employees
Funding Data
Aurobindo Pharma has never raised funding before.
Aurobindo Pharma Tech Stack
Discover the technologies and tools that power Aurobindo Pharma's digital infrastructure, from frameworks to analytics platforms.
Programming languages
JavaScript libraries
JavaScript libraries
JavaScript libraries
Maps
UI frameworks
JavaScript libraries
Web frameworks
CDN
JavaScript libraries
Security
Analytics
France
Portugal
Saudi Arabia
United Arab Emirates
Canada
United KingdomFrequently asked questions
4.8
40,000 users
